España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
HOOKIPA Pharma
HOOK
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.95
0.01
0.52%
At close: -
$1.98
0.03
1.53%
After Hours: Jan 17, 7:35 PM EDT
Get Report
Comment
HOOKIPA Pharma (HOOK) Forecast
News
Earnings
HOOKIPA Pharma (HOOK) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for HOOKIPA Pharma (NASDAQ:HOOK) Stock
HOOKIPA Pharma Stock (NASDAQ: HOOK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 10, 2025
HC Wainwright & Co. Downgrades HOOKIPA Pharma...
Benzinga Newsdesk
Friday, January 03, 2025
Deal Dispatch: Vera Bradley Is A Mixed Bag, Modell's Ex-CEO Explores Party City
Anthony Noto
Friday, December 20, 2024
RBC Capital Downgrades HOOKIPA Pharma to Sect...
Benzinga Newsdesk
Thursday, November 21, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Friday, November 15, 2024
RBC Capital Maintains Outperform on HOOKIPA P...
Benzinga Newsdesk
Thursday, November 14, 2024
HOOKIPA Pharma Q3 2024 GAAP EPS $(1.10) Beats...
Benzinga Newsdesk
Monday, November 11, 2024
HOOKIPA Pharma Presented Updated Phase 2 Data...
Benzinga Newsdesk
Thursday, October 31, 2024
HOOKIPA Pharma To Present Eseba-vec Combo On ...
Benzinga Newsdesk
Wednesday, October 30, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
HOOKIPA Pharma Says Initial Safety And Effica...
Benzinga Newsdesk
Researchers At Memorial Sloan Kettering Cance...
Benzinga Newsdesk
Tuesday, September 24, 2024
Hookipa Pharma Says It Will Present Preclinic...
Nabaparna Bhattacharya
Friday, August 09, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Thursday, August 08, 2024
Hookipa Pharma Q2 2024 Revenue $1.3M
Benzinga Newsdesk
Generation Bio Co. Reports Q2 Loss, Tops Revenue Estimates
Zacks
Friday, July 26, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Monday, July 22, 2024
HOOKIPA Pharma Announces Director Dr. Malte P...
Benzinga Newsdesk
Wednesday, July 10, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Tuesday, July 09, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Monday, July 08, 2024
Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today
Henry Khederian
HOOKIPA Pharma shares are trading lower after...
Benzinga Newsdesk
HOOKIPA Pharma to Implement 1-for-10 Reverse ...
Benzinga Newsdesk
Monday, July 01, 2024
HOOKIPA Pharma Doses First Person In Phase 1b...
Benzinga Newsdesk
Wednesday, June 05, 2024
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on HOOKIPA ...
Benzinga Newsdesk
Tuesday, June 04, 2024
HOOKIPA Pharma Announces Phase 2 Results For ...
Benzinga Newsdesk
Monday, May 27, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, May 24, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, May 21, 2024
Deep Dive Into HOOKIPA Pharma Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
RBC Capital Reiterates Outperform on HOOKIPA ...
Benzinga Newsdesk
Thursday, May 09, 2024
HOOKIPA Pharma Q1 2024 GAAP EPS $0.11 Beats $...
Benzinga Newsdesk
Friday, April 26, 2024
Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
Benzinga Insights
HC Wainwright & Co. Maintains Buy on HOOKIPA ...
Benzinga Newsdesk
Thursday, April 25, 2024
HOOKIPA Pharma Announced Its Final Pivotal Ph...
Benzinga Newsdesk
Wednesday, April 24, 2024
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Vandana Singh
HOOKIPA Pharma shares are trading higher afte...
Benzinga Newsdesk
HOOKIPA Pharma Received FDA Clearance For Its...
Benzinga Newsdesk
Monday, April 15, 2024
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
Vandana Singh
Wednesday, April 10, 2024
HOOKIPA Pharma Announced That Members Of Its ...
Benzinga Newsdesk
Monday, March 25, 2024
RBC Capital Reiterates Outperform on HOOKIPA ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on HOOKIPA...
Benzinga Newsdesk
Friday, March 22, 2024
HOOKIPA Pharma: Q4 Earnings Insights
Benzinga Insights
HOOKIPA Pharma Q4 EPS $(0.22) Misses $(0.19) ...
Benzinga Newsdesk
Tuesday, February 13, 2024
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
Vandana Singh
Thursday, February 08, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Thursday, February 01, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, January 30, 2024
RBC Capital Maintains Outperform on HOOKIPA P...
Benzinga Newsdesk
Monday, January 29, 2024
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
Vandana Singh
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
